A combination approach, which included metabolic reprogramming and immunotherapy, led to complete tumor regression in 60% of study mice.

Researchers have demonstrated that a new liquid biopsy approach overcomes traditional barriers to quickly and efficiently diagnose and monitor high-grade gliomas.

A roundup of several recent Michigan Medicine discoveries that are shedding new light on pediatric brain cancers and helping to improve treatment options.

In mouse models of DIPG, simultaneously attacking two metabolic pathways led to significant improvements in survival.

Anti-androgen therapy showed positive results in cell lines and animal models.

Laboratory research paves the way for a clinical trial to see if an FDA-approved drug used to prevent organ transplant rejection can work against these aggressive brain tumors.